Sandrine Bourgeois

Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.

Maria-João Ribeiro, Pascale de Lonlay, Thierry Delzescaux et al. · PubMed · 2005 · 168 citations

The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children

Maria-João Ribeiro, Nathalie Boddaert, Christine Bellanné‐Chantelot et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 74 citations

Retrospective Study, Inherited Metabolic Disease, Pediatrics +5

Nano-encapsulation of Vitamin D3 Active Metabolites for Application in Chemotherapy: Formulation Study and in Vitro Evaluation

Eyad Almouazen, Sandrine Bourgeois, Lars Petter Jordheim et al. · Pharmaceutical Research · 2012 · 68 citations

Nanomedicine, Pharmaceutical Science, Formulation Study +6

Evaluation of critical formulation parameters influencing the bioactivity of β-lactamases entrapped in pectin beads

Sandrine Bourgeois, Muriel Gernet, D. Pradeau et al. · International Journal of Pharmaceutics · 2006 · 66 citations

Critical Formulation Parameters, Antimicrobial Packaging, Engineering +10

Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone

Claire Leroy, Véronique Bragulat, Ivan Berlin et al. · Journal of Clinical Psychopharmacology · 2009 · 54 citations